Who owns the KATAMARYN trademark?

The KATAMARYN trademark is owned by Boston Pharmaceuticals, Inc..

What class is the KATAMARYN trademark registered in?

The KATAMARYN trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for KATAMARYN?

The USPTO serial number for KATAMARYN is 98209131.

What is the registration number for KATAMARYN?

KATAMARYN is registered under USPTO registration number 0.

Sealvo

Home Search: KATAMARYNKATAMARYN #98209131

Back

Updated Oct 24, 2026·8 searches this week

View on USPTO TSDR Find similar marks

KAT

USPTO Trademark Record

ABANDONED

KATAMARYN

SN 98209131·Reg 0·Filed Oct 04, 2023

Owner Boston Pharmaceuticals, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

KATAMARYN (Serial No. 98209131), Registration No. 0, is a abandoned US trademark filed on Oct 04, 2023 by Boston Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

KATAMARYN (Reg. #0) is an abandoned US trademark that was filed in 2023 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 04, 2023

SERIAL

98209131

REG#

Filing Information

StatusABANDONED

Filing DateOct 04, 2023

Serial Number98209131

Registration No.0

Status DateNov 10, 2025

Published for OppositionFeb 11, 2025

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters Claimed

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1792638

499Mar 21, 2024

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

17 events

ABANDONMENT - NO USE STATEMENT FILED

Nov 10, 2025

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Nov 10, 2025

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 08, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 11, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 11, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 05, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 19, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Jan 17, 2025

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 17, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 17, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Dec 23, 2024

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

SUSPENSION LETTER WRITTEN

May 24, 2024

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

May 24, 2024

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

May 24, 2024

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

ASSIGNED TO EXAMINER

May 23, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 13, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 07, 2023

NEW APPLICATION ENTERED

Other Marks by Boston Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

KAT

KATAMARYN

98323695

Boston Pharmaceuticals, Inc.

ABANDONED

KAT

KATAMARYN

98209144

Boston Pharmaceuticals, Inc.

ABANDONED

TRA

TRANSFORMING THE RIGHT MOLECULES INTO THE BEST MEDICINES

87728454

Boston Pharmaceuticals, Inc.

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

KAT

KATAMARYN

98323695

Boston Pharmaceuticals, Inc.

ABANDONED

KAT

KATAMARYN

98209144

Boston Pharmaceuticals, Inc.

ABANDONED

Other Marks by Camille M. Miller

Additional USPTO filings handled by the same attorney of record.

LAC

LA CHIMBA

88725927

REGISTERED

PAR

PAR HEALTH

99169735

REGISTERED

WEA

WE ARE TROON

99271734

REGISTERED

LCB

LC BRACKETS

98547415

REGISTERED

KATAMARYN

Run a conflict check

Other Marks by Boston Pharmaceuticals, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Camille M. Miller

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company